The impact of diagnosis subject to reimbursement on life expectancy, the ability to work, and the quality of life: The experts' assessment

Research output: Contribution to journalConference articlepeer-review

Abstract

The ex-post retrospective analysis of the health care reform in Latvia has been performed by several authors; therefore in writing this paper, the author also considered it essential to try and predict its future prospects, specifically, to carry out an ex-ante analysis of reimbursement arrangements for medicines and medical devices in outpatient treatment (“reimbursement arrangements”). An ex-antepolicy impact analysis takes place at the beginning of the policy development process when policy planners and experts try to project, by means of various quantitative and qualitative methods, the various kinds of consequences that the society will face as a result of implementation of the policy. Taking into account the circumstances of limited state budget resources for the medicines reimbursement arrangements in Latvia, the aim of this research is to evaluate by the experts’ method the impact of the reimbursed diseases on the life expectancy, the ability to work, and the quality of life, to identify the priorities. According to the experts’ judgments the group of diagnoses “Neoplasms” gives the greatest common impact on the life expectancy, the ability to work, and quality of life, followed by the “Diseases of the circulatory system” and “Diseases of the blood and blood forming organs and certain disorders involving the immune mechanisms”.
Original languageEnglish
Article number00004
JournalSHS Web of Conferences
Volume10
DOIs
Publication statusPublished - 2014
Event4th International Interdisciplinary Scientific Conference SOCIETY, HEALTH, WELFARE - Riga, Latvia
Duration: 22 Nov 201223 Nov 2012
Conference number: 4

Field of Science

  • 3.3 Health sciences

Publication Type

  • 1.1. Scientific article indexed in Web of Science and/or Scopus database

Fingerprint

Dive into the research topics of 'The impact of diagnosis subject to reimbursement on life expectancy, the ability to work, and the quality of life: The experts' assessment'. Together they form a unique fingerprint.

Cite this